Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
McKinsey
Fuji
Argus Health
QuintilesIMS
Chinese Patent Office
Boehringer Ingelheim
Fish and Richardson
AstraZeneca

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089102

« Back to Dashboard

NDA 089102 describes FEMCET, which is a drug marketed by Mallinckrodt and is included in one NDA. Additional details are available on the FEMCET profile page.

The generic ingredient in FEMCET is acetaminophen; butalbital; caffeine. There are sixty-six drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.
Summary for 089102
Tradename:FEMCET
Applicant:Mallinckrodt
Ingredient:acetaminophen; butalbital; caffeine
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength325MG;50MG;40MG
Approval Date:Jun 19, 1985TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Deloitte
Accenture
Farmers Insurance
Daiichi Sankyo
Queensland Health
Mallinckrodt
Harvard Business School
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.